Plain-English translation of NCT06888193 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers want to understand how much of a medication called passes into breast milk when mothers take it while breastfeeding. This information will help doctors and mothers make informed decisions about whether it's safe to continue this treatment while nursing a baby. The study simply collects and measures breast milk samples from mothers who are already being treated with this medication under their doctor's care.
Many women with psoriasis, arthritis, and related conditions need ongoing treatment to stay healthy, but there's limited information about how much of this medication reaches breast milk. By collecting this data, doctors can better counsel breastfeeding mothers about the safety of continuing this treatment while nursing.
You likely qualify if…
You likely don't qualify if…
You would continue taking your medication exactly as your doctor prescribed — nothing changes about your treatment. During a designated sampling period, you would provide breast milk samples that researchers test to measure how much medication is present. You'll need to have been on this treatment for at least 12 weeks after delivery, and you'll continue breastfeeding normally throughout your participation.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Canada